Suchbegriffe: INFLAMMATION - DRUG THERAPY , . Treffer: 31
Pipper, C; Bordag, N; Reiter, B; Economides, K; Florian, P; Birngruber, T; Sinner, F; Bodenlenz, M; Eberl, A
LC/MS/MS analyses of open-flow microperfusion samples quantify eicosanoids in a rat model of skin inflammation.
J Lipid Res. 2019; 60(4):758-766
Doi: 10.1194/jlr.M087221
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Rittchen, S; Heinemann, A
Therapeutic Potential of Hematopoietic Prostaglandin D2 Synthase in Allergic Inflammation.
Cells. 2019; 8(6):
Doi: 10.3390/cells8060619
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Wolf, D; Anto-Michel, N; Blankenbach, H; Wiedemann, A; Buscher, K; Hohmann, JD; Lim, B; Bäuml, M; Marki, A; Mauler, M; Duerschmied, D; Fan, Z; Winkels, H; Sidler, D; Diehl, P; Zajonc, DM; Hilgendorf, I; Stachon, P; Marchini, T; Willecke, F; Schell, M; Sommer, B; von Zur Muhlen, C; Reinöhl, J; Gerhardt, T; Plow, EF; Yakubenko, V; Libby, P; Bode, C; Ley, K; Peter, K; Zirlik, A
A ligand-specific blockade of the integrin Mac-1 selectively targets pathologic inflammation while maintaining protective host-defense.
Nat Commun. 2018; 9(1):525-525
Doi: 10.1038/s41467-018-02896-8
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Theiler, A; Konya, V; Pasterk, L; Maric, J; Bärnthaler, T; Lanz, I; Platzer, W; Schuligoi, R; Heinemann, A
The EP1/EP3 receptor agonist 17-pt-PGE2 acts as an EP4 receptor agonist on endothelial barrier function and in a model of LPS-induced pulmonary inflammation.
Vascul Pharmacol. 2016; 87(4):180-189
Doi: 10.1016/j.vph.2016.09.008
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Holzer, P; Hassan, AM; Jain, P; Reichmann, F; Farzi, A
Neuroimmune pharmacological approaches.
Curr Opin Pharmacol. 2015; 25:13-22
Doi: 10.1016/j.coph.2015.09.003
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Mangge, H; Weghuber, D; Prassl, R; Haara, A; Schnedl, W; Postolache, TT; Fuchs, D
The Role of Vitamin D in Atherosclerosis Inflammation Revisited: More a Bystander than a Player?
Curr Vasc Pharmacol. 2015; 13(3):392-398
Doi: 10.2174/1570161111666131209125454
Web of Science
PubMed
FullText
FullText_MUG
Mischinger, J; Comperat, E; Schwentner, C; Stenzl, A; Gakis, G
Inflammation and Cancer: What Can We Therapeutically Expect from Checkpoint Inhibitors?
Curr Urol Rep. 2015; 16(9):59-59
Doi: 10.1007/s11934-015-0532-8
Web of Science
PubMed
FullText
FullText_MUG
Sombetzki, M; Fuchs, CD; Fickert, P; Österreicher, CH; Mueller, M; Claudel, T; Loebermann, M; Engelmann, R; Langner, C; Sahin, E; Schwinge, D; Guenther, ND; Schramm, C; Mueller-Hilke, B; Reisinger, EC; Trauner, M
24-nor-ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasis.
J Hepatol. 2015; 62(4):871-878
Doi: 10.1016/j.jhep.2014.11.020
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Ficjan, A; Husic, R; Gretler, J; Lackner, A; Graninger, WB; Gutierrez, M; Duftner, C; Hermann, J; Dejaco, C
Ultrasound composite scores for the assessment of inflammatory and structural pathologies in Psoriatic Arthritis (PsASon-Score).
Arthritis Res Ther. 2014; 16(5): 476-488.
Doi: 10.1186/s13075-014-0476-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Gylling, H; Plat, J; Turley, S; Ginsberg, HN; Ellegard, L; Jessup, W; Jones, PJ; Lutjohann, D; Maerz, W; Masana, L; Silbernagel, G; Staels, B; Boren, J; Catapano, AL; De Backer, G; Deanfield, J; Descamps, OS; Kovanen, PT; Riccardi, G; Tokgozoglu, L; Chapman, MJ
Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease
ATHEROSCLEROSIS. 2014; 232(2): 346-360.
Doi: 10.1016/j.atherosclerosis.2013.11.043
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Hafner, F; Hackl, G; Haas, E; Eller, P; Gstettner, C; Vollmann, R; Brodmann, M
Idiopathic carotidynia.
Vasa. 2014; 43(4):287-292
Doi: 10.1024/0301-1526/a000365
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Schaap, FG; Trauner, M; Jansen, PL
Bile acid receptors as targets for drug development.
Nat Rev Gastroenterol Hepatol. 2014; 11(1):55-67
Doi: 10.1038/nrgastro.2013.151
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Schwabl, P; Payer, BA; Grahovac, J; Klein, S; Horvatits, T; Mitterhauser, M; Stift, J; Boucher, Y; Trebicka, J; Trauner, M; Angermayr, B; Fuhrmann, V; Reiberger, T; Peck-Radosavljevic, M
Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive rats.
J Hepatol. 2014; 60(6): 1135-1142.
Doi: 10.1016/j.jhep.2014.01.025
Web of Science
PubMed
FullText
FullText_MUG
Adzemovic, MZ; Zeitelhofer, M; Hochmeister, S; Gustafsson, SA; Jagodic, M
Efficacy of vitamin D in treating multiple sclerosis-like neuroinflammation depends on developmental stage.
Exp Neurol. 2013; 249(12):39-48
Doi: 10.1016/j.expneurol.2013.08.002
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Itariu, BK; Zeyda, M; Leitner, L; Marculescu, R; Stulnig, TM
Treatment with n-3 polyunsaturated fatty acids overcomes the inverse association of vitamin D deficiency with inflammation in severely obese patients: a randomized controlled trial.
PLoS One. 2013; 8(1): e54634-e54634.
Doi: 10.1371/journal.pone.0054634
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Neuhofer, A; Zeyda, M; Mascher, D; Itariu, BK; Murano, I; Leitner, L; Hochbrugger, EE; Fraisl, P; Cinti, S; Serhan, CN; Stulnig, TM
Impaired local production of proresolving lipid mediators in obesity and 17-HDHA as a potential treatment for obesity-associated inflammation.
Diabetes. 2013; 62(6): 1945-1956.
Doi: 10.2337/db12-0828
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Singh, TP; Schön, MP; Wallbrecht, K; Gruber-Wackernagel, A; Wang, XJ; Wolf, P
Involvement of IL-9 in Th17-associated inflammation and angiogenesis of psoriasis.
PLoS One. 2013; 8(1):e51752-e51752
Doi: 10.1371/journal.pone.0051752
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Smolen, JS; Schoels, MM; Nishimoto, N; Breedveld, FC; Burmester, GR; Dougados, M; Emery, P; Ferraccioli, G; Gabay, C; Gibofsky, A; Gomez-Reino, JJ; Jones, G; Kvien, TK; Murakami, M; Betteridge, N; Bingham, CO; Bykerk, V; Choy, EH; Combe, B; Cutolo, M; Graninger, W; Lanas, A; Martin-Mola, E; Montecucco, C; Ostergaard, M; Pavelka, K; Rubbert-Roth, A; Sattar, N; Scholte-Voshaar, M; Tanaka, Y; Trauner, M; Valentini, G; Winthrop, KL; de Wit, M; van der Heijde, D
Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions.
Ann Rheum Dis. 2013; 72(4):482-492
Doi: 10.1136/annrheumdis-2012-202469
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Tripolt, NJ; Leber, B; Blattl, D; Eder, M; Wonisch, W; Scharnagl, H; Stojakovic, T; Obermayer-Pietsch, B; Wascher, TC; Pieber, TR; Stadlbauer, V; Sourij, H
Short communication: Effect of supplementation with Lactobacillus casei Shirota on insulin sensitivity, β-cell function, and markers of endothelial function and inflammation in subjects with metabolic syndrome--a pilot study.
J Dairy Sci. 2013; 96(1):89-95
Doi: 10.3168/jds.2012-5863
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Hilgendorf, I; Eisele, S; Remer, I; Schmitz, J; Zeschky, K; Colberg, C; Stachon, P; Wolf, D; Willecke, F; Buchner, M; Zirlik, K; Ortiz-Rodriguez, A; Lozhkin, A; Hoppe, N; von zur Muhlen, C; zur Hausen, A; Bode, C; Zirlik, A
The oral spleen tyrosine kinase inhibitor fostamatinib attenuates inflammation and atherogenesis in low-density lipoprotein receptor-deficient mice.
ARTERIOSCL THROM VAS. 2011; 31(9): 1991-1999.
Doi: 10.1161/ATVBAHA.111.230847
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Schuligoi, R; Sturm, E; Luschnig, P; Konya, V; Philipose, S; Sedej, M; Waldhoer, M; Peskar, BA; Heinemann, A
CRTH2 and D-type prostanoid receptor antagonists as novel therapeutic agents for inflammatory diseases.
Pharmacology. 2010; 85(6): 372-382.
Doi: 10.1159/000313836
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Schernthaner, G; Forst, T; Gulba, D; Haberbosch, W; Hanefeld, M; Linss, G; März, W; Mehnert, H; Rosak, C; Schnell, O; Seufert, J; Tschöpe, D; Erdmann, E
Challenge in diabetes therapy: effects of glitazones beyond blood glucose control].
Dtsch Med Wochenschr. 2009; 134(18):949-954
Doi: 10.1055/s-0029-1220255
Web of Science
PubMed
FullText
FullText_MUG
Eisendle, K; Linder, D; Ratzinger, G; Zelger, B; Philipp, W; Piza, H; Fritsch, P; Schmuth, M
Inflammation and lipid accumulation in xanthoma disseminatum: Therapeutic considerations.
J Am Acad Dermatol. 2008; 58(2 Suppl): S47-S49.
Doi: 10.1016/j.jaad.2006.05.032
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Kessenbrock, K; Fröhlich, L; Sixt, M; Lämmermann, T; Pfister, H; Bateman, A; Belaaouaj, A; Ring, J; Ollert, M; Fässler, R; Jenne, DE
Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin.
J Clin Invest. 2008; 118(7): 2438-2447.
Doi: 10.1172/JCI34694
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Krane, V; Winkler, K; Drechsler, C; Lilienthal, J; März, W; Wanner, C; German Diabetes and Dialysis Study Investigators
Effect of atorvastatin on inflammation and outcome in patients with type 2 diabetes mellitus on hemodialysis.
Kidney Int. 2008; 74(11):1461-1467
Doi: 10.1038/ki.2008.484
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Meisner, F; Walcher, D; Gizard, F; Kapfer, X; Huber, R; Noak, A; Sunder-Plassmann, L; Bach, H; Haug, C; Bachem, M; Stojakovic, T; März, W; Hombach, V; Koenig, W; Staels, B; Marx, N
Effect of rosiglitazone treatment on plaque inflammation and collagen content in nondiabetic patients: data from a randomized placebo-controlled trial.
Arterioscler Thromb Vasc Biol. 2006; 26(4):845-850
Doi: 10.1161/01.ATV.0000203511.66681.7f
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Wolf, P; Nghiem, DX; Walterscheid, JP; Byrne, S; Matsumura, Y; Matsumura, Y; Bucana, C; Ananthaswamy, HN; Ullrich, SE
Platelet-activating factor is crucial in psoralen and ultraviolet A-induced immune suppression, inflammation, and apoptosis.
AMER J PATHOL. 2006; 169(3): 795-805.
Doi: 10.1253/ajpath.2006.060079
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Zhong, Z; Wheeler, MD; Li, X; Froh, M; Schemmer, P; Yin, M; Bunzendaul, H; Bradford, B; Lemasters, JJ
L-Glycine: a novel antiinflammatory, immunomodulatory, and cytoprotective agent.
Curr Opin Clin Nutr Metab Care. 2003; 6(2):229-240
Doi: 10.1097/01.mco.0000058609.19236.a4
Web of Science
PubMed
FullText
FullText_MUG
Amann, R; Lanz, I; Schuligoi, R
Effects of morphine on oedema and tissue concentration of nerve growth factor in experimental inflammation of the rat paw.
Pharmacology. 2002; 66(3):169-172
Doi: 10.1159/000063800
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Amann, R; Peskar, BA; Schuligoi, R
Effects of terbutaline on NGF formation in allergic inflammation of the rat.
Br J Pharmacol. 2001; 133(1):186-192
Doi: 10.1038/sj.bjp.0704060
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Wheeler, MD; Ikejema, K; Enomoto, N; Stacklewitz, RF; Seabra, V; Zhong, Z; Yin, M; Schemmer, P; Rose, ML; Rusyn, I; Bradford, B; Thurman, RG
Glycine: a new anti-inflammatory immunonutrient.
Cell Mol Life Sci. 1999; 56(9-10):843-856
Doi: 10.1007/s000180050030
Web of Science
PubMed
FullText
FullText_MUG